Orthocell LtdASX: OCC

AGM Addresses by Chair and Managing Director

· Issued by Orthocell Ltd via ASX

Filed with ASX · · 30 pages · English

Summary by 6ix AI

Orthocell Ltd has released the addresses from its Annual General Meeting delivered by the Chair and Managing Director, highlighting the company's progress and future strategies. The Chair acknowledged the recent share price performance and emphasized the company's transformation from a development-stage biotechnology firm to a commercial organization. The presentation outlines strong revenue growth and the increasing adoption of its flagship product, Remplir, particularly in the U.S. market. The company remains focused on expanding its global footprint and enhancing shareholder value through disciplined growth and operational excellence.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/agm-addresses-by-chair-and-managing-director-1

Release

ASX Announcement Annual General Meeting Address by Chair and Managing Director Perth, Australia; 6 November 2026: Regenerative medicine company Orthocell Limited (ASX: OCC, “Orthocell” or “the Company”) is pleased to provide copies of the addresses to be delivered by the Chair and Managing...

Orthocell Ltd on 6ix

In the deck

Earlier from Orthocell

Later from Orthocell

All Orthocell news releases